These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 26945988)

  • 1. A vaccine consisting of Schistosoma mansoni cathepsin B formulated in Montanide ISA 720 VG induces high level protection against murine schistosomiasis.
    Ricciardi A; Visitsunthorn K; Dalton JP; Ndao M
    BMC Infect Dis; 2016 Mar; 16():112. PubMed ID: 26945988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant.
    Ricciardi A; Dalton JP; Ndao M
    Vaccine; 2015 Jan; 33(2):346-53. PubMed ID: 25448114
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Morais SB; Figueiredo BC; Assis NRG; Homan J; Mambelli FS; Bicalho RM; Souza C; Martins VP; Pinheiro CS; Oliveira SC
    Front Immunol; 2018; 9():1762. PubMed ID: 30105029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Mechanisms Involved in
    Ricciardi A; Zelt NH; Visitsunthorn K; Dalton JP; Ndao M
    Front Immunol; 2018; 9():1710. PubMed ID: 30090103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine.
    Zhang W; Ahmad G; Torben W; Noor Z; Le L; Damian RT; Wolf RF; White GL; Chavez-Suarez M; Podesta RB; Kennedy RC; Siddiqui AA
    J Infect Dis; 2010 Apr; 201(7):1105-12. PubMed ID: 20187746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection.
    Gonçalves de Assis NR; Batistoni de Morais S; Figueiredo BC; Ricci ND; de Almeida LA; da Silva Pinheiro C; Martins Vde P; Oliveira SC
    PLoS One; 2015; 10(5):e0125075. PubMed ID: 25942636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvanted
    Perera DJ; Hassan AS; Jia Y; Ricciardi A; McCluskie MJ; Weeratna RD; Ndao M
    Front Immunol; 2020; 11():605288. PubMed ID: 33304354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice.
    Ahmad G; Zhang W; Torben W; Noor Z; Siddiqui AA
    Int J Infect Dis; 2010 Sep; 14(9):e781-7. PubMed ID: 20630783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A low dose adenovirus vectored vaccine expressing Schistosoma mansoni Cathepsin B protects from intestinal schistosomiasis in mice.
    Perera DJ; Hassan AS; Liu SS; Elahi SM; Gadoury C; Weeratna RD; Gilbert R; Ndao M
    EBioMedicine; 2022 Jun; 80():104036. PubMed ID: 35500538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immune responses against Schistosoma mansoni infection by immunization with functionally active gut-derived cysteine peptidases alone and in combination with glyceraldehyde 3-phosphate dehydrogenase.
    Tallima H; Dvořák J; Kareem S; Abou El Dahab M; Abdel Aziz N; Dalton JP; El Ridi R
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005443. PubMed ID: 28346516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection.
    Cardoso FC; Macedo GC; Gava E; Kitten GT; Mati VL; de Melo AL; Caliari MV; Almeida GT; Venancio TM; Verjovski-Almeida S; Oliveira SC
    PLoS Negl Trop Dis; 2008 Oct; 2(10):e308. PubMed ID: 18827884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with rP22 induces protective immunity against Schistosoma mansoni: effects on granuloma down-modulation and cytokine production.
    Rezende CM; Silva MR; Santos IG; Silva GA; Gomes DA; Goes AM
    Immunol Lett; 2011 Dec; 141(1):123-33. PubMed ID: 21945176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model.
    Ahmad G; Zhang W; Torben W; Damian RT; Wolf RF; White GL; Chavez-Suarez M; Kennedy RC; Siddiqui AA
    Vaccine; 2009 May; 27(21):2830-7. PubMed ID: 19366570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sm-p80-based DNA vaccine made in a human use approved vector VR1020 protects against challenge infection with Schistosoma mansoni in mouse.
    Zhang W; Ahmad G; Torben W; Siddiqui AA
    Parasite Immunol; 2010 Apr; 32(4):252-8. PubMed ID: 20398225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni.
    Ahmad G; Torben W; Zhang W; Wyatt M; Siddiqui AA
    Parasite Immunol; 2009 Mar; 31(3):156-61. PubMed ID: 19222788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-administration of plasmid expressing IL-12 with 14-kDa Schistosoma mansoni fatty acid-binding protein cDNA alters immune response profiles and fails to enhance protection induced by Sm14 DNA vaccine alone.
    Fonseca CT; Pacífico LG; Barsante MM; Rassi T; Cassali GD; Oliveira SC
    Microbes Infect; 2006 Aug; 8(9-10):2509-16. PubMed ID: 16914349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine.
    Ahmad G; Zhang W; Torben W; Haskins C; Diggs S; Noor Z; Le L; Siddiqui AA
    Parasitol Res; 2009 Nov; 105(6):1767-77. PubMed ID: 19809833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticity.
    El Ridi R; Tallima H; Selim S; Donnelly S; Cotton S; Gonzales Santana B; Dalton JP
    PLoS One; 2014; 9(1):e85401. PubMed ID: 24465551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons.
    Karmakar S; Zhang W; Ahmad G; Torben W; Alam MU; Le L; Damian RT; Wolf RF; White GL; Carey DW; Carter D; Reed SG; Siddiqui AA
    Vaccine; 2014 Mar; 32(11):1296-303. PubMed ID: 24397898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saposin-like proteins are expressed in the gastrodermis of Schistosoma mansoni and are immunogenic in natural infections.
    Don TA; Bethony JM; Loukas A
    Int J Infect Dis; 2008 Nov; 12(6):e39-47. PubMed ID: 18571965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.